BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734
75830 results:

  • 1. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mapping recurrent mosaic copy number variation in human neurons.
    Sun C; Kathuria K; Emery SB; Kim B; Burbulis IE; Shin JH; ; Weinberger DR; Moran JV; Kidd JM; Mills RE; McConnell MJ
    Nat Commun; 2024 May; 15(1):4220. PubMed ID: 38760338
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Alkylating agents are possible inducers of glioblastoma and other brain tumors.
    Smith CJ; Perfetti TA; Chokshi C; Venugopal C; Ashford JW; Singh SK
    Hum Exp Toxicol; 2024; 43():9603271241256598. PubMed ID: 38758727
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression.
    Garcia-Montojo M; Fathi S; Rastegar C; Simula ER; Doucet-O'Hare T; Cheng YHH; Abrams RPM; Pasternack N; Malik N; Bachani M; Disanza B; Maric D; Lee MH; Wang H; Santamaria U; Li W; Sampson K; Lorenzo JR; Sanchez IE; Mezghrani A; Li Y; Sechi LA; Pineda S; Heiman M; Kellis M; Steiner J; Nath A
    Nat Commun; 2024 May; 15(1):4163. PubMed ID: 38755145
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
    Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
    BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnosis rates, therapeutic characteristics, lifestyle, and cancer screening habits of patients with diabetes mellitus in a highly deprived region in Hungary: a cross-sectional analysis.
    Pártos K; Major D; Dósa N; Fazekas-Pongor V; Tabak AG; Ungvári Z; Horváth I; Barta I; Pozsgai É; Bodnár T; Fehér G; Lenkey Z; Fekete M; Springó Z
    Front Endocrinol (Lausanne); 2024; 15():1299148. PubMed ID: 38752177
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome.
    Frelinger AL; Haynes RL; Goldstein RD; Berny-Lang MA; Gerrits AJ; Riehs M; Haas EA; Paunovic B; Mena OJ; Campman SC; Milne GL; Sleeper LA; Kinney HC; Michelson AD
    Sci Rep; 2024 May; 14(1):11092. PubMed ID: 38750089
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prediction of treatment response after stereotactic radiosurgery of brain metastasis using deep learning and radiomics on longitudinal MRI data.
    Cho SJ; Cho W; Choi D; Sim G; Jeong SY; Baik SH; Bae YJ; Choi BS; Kim JH; Yoo S; Han JH; Kim CY; Choo J; Sunwoo L
    Sci Rep; 2024 May; 14(1):11085. PubMed ID: 38750084
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MAPP unravels frequent co-regulation of splicing and polyadenylation by RNA-binding proteins and their dysregulation in cancer.
    Bak M; van Nimwegen E; Kouzel IU; Gur T; Schmidt R; Zavolan M; Gruber AJ
    Nat Commun; 2024 May; 15(1):4110. PubMed ID: 38750024
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. METTL8 links mt-tRNA m
    Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
    Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
    Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
    Ji Q; McAfee SS; Scoggins M; Holtrop J; Glass JO; Yuan X; Liang J; Li Y; Chiang J; Orr BA; Edwards A; Storment D; Brinkman T; Robinson GW; Gajjar A; Reddick WE; Patay Z; Khan RB; Bag AK
    Radiology; 2024 May; 311(2):e232521. PubMed ID: 38742969
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epidemiology and Management Trends of Neuro-Oncology in Nigeria: A Systematic Review and Pooled Analysis.
    Ukachukwu AK; Seas A; Oboh EC; Paradie E; Oyemolade TA; Nwaribe EE; Nischal SA; Hughes JG; Ogundeji OD; Badejo OA; Malomo TA; Okere OE; Abu-Bonsrah N; Still MEH; Waguia-Kouam R; Trillo-Ordonez Y; Asemota I; Oboh EN; Rahman R; Reddy P; Ugorji C; von Isenburg M; Fuller AT; Haglund MM; Adeleye AO
    World Neurosurg; 2024 May; 185():e185-e208. PubMed ID: 38741325
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3792.